The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Zur, Arik A.
Funding for this research was provided by:
Teva Pharmaceutical Industries
Text and Data Mining valid from 2018-09-06